Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Plan To Sue A Slipshod Supplier To Recoup A Civil Litigation Judgment? When It Comes To Implantable Device Parts, You May Have To Think Again

This article was originally published in The Gray Sheet

Executive Summary

While negligent suppliers of failing components are typically sued by end-product manufacturers to recover their fair share of civil or government money damages, vendors that sell parts for most implantable devices are largely shielded from liability by a not-oft-talked-about federal act. The Biomaterials Assurance Act of 1998 "provides immunity for suppliers of components in medical devices based on the notion that it’s the manufacturer of the actual device that is responsible for ensuring the safety of the products before they’re put onto market," attorney Lauren Colton says. "And under that act, a component part-maker is given immunity." Also: Device-maker B. Braun might have a long row to hoe if it chooses to recoup litigation costs from its former supplier of syringes. That's because the manufacturer knew the syringes were possibly contaminated and sold them anyway, leading to a nearly $8m penalty from the US Department of Justice.

You may also be interested in...



Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot

In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?

Thumbs Up: FDA Authorizes Weight Loss Suturing Systems From Apollo Endosurgery

People with obesity now have new tools to help them lose weight, thanks to the US agency’s de novo authorization.

FDA Slaps High Risk Class I Label On Recall Of COVID-19 Diagnostics Made In Uncontrolled Plant

More than 160,000 of the tests were recalled, including 104,900 COVID Test Kits Nonsterile and 61,500 Clean Catch Urine Kits.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT038352

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel